BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32071317)

  • 1. A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions.
    Grossi E; Raimondi I; Goñi E; González J; Marchese FP; Chapaprieta V; Martín-Subero JI; Guo S; Huarte M
    Nat Commun; 2020 Feb; 11(1):936. PubMed ID: 32071317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.
    Sasaki M; Kato D; Murakami K; Yoshida H; Takase S; Otsubo T; Ogiwara H
    Nat Commun; 2024 Jun; 15(1):4770. PubMed ID: 38839769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
    Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
    Gene; 2019 May; 696():1-9. PubMed ID: 30735718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
    Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
    Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
    Radko-Juettner S; Yue H; Myers JA; Carter RD; Robertson AN; Mittal P; Zhu Z; Hansen BS; Donovan KA; Hunkeler M; Rosikiewicz W; Wu Z; McReynolds MG; Roy Burman SS; Schmoker AM; Mageed N; Brown SA; Mobley RJ; Partridge JF; Stewart EA; Pruett-Miller SM; Nabet B; Peng J; Gray NS; Fischer ES; Roberts CWM
    Nature; 2024 Apr; 628(8007):442-449. PubMed ID: 38538798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer.
    Tang Y; Wang J; Lian Y; Fan C; Zhang P; Wu Y; Li X; Xiong F; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2017 Feb; 16(1):42. PubMed ID: 28212646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.
    Drosos Y; Myers JA; Xu B; Mathias KM; Beane EC; Radko-Juettner S; Mobley RJ; Larsen ME; Piccioni F; Ma X; Low J; Hansen BS; Peters ST; Bhanu NV; Dhanda SK; Chen T; Upadhyaya SA; Pruett-Miller SM; Root DE; Garcia BA; Partridge JF; Roberts CWM
    Mol Cell; 2022 Jul; 82(13):2472-2489.e8. PubMed ID: 35537449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5.
    Li M; Shen Y; Xiong Y; Wang S; Li C; Bai J; Zhang Y
    Cell Prolif; 2021 Dec; 54(12):e13136. PubMed ID: 34668612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.
    Idogawa M; Ohashi T; Sasaki Y; Nakase H; Tokino T
    Int J Cancer; 2017 Jun; 140(12):2785-2791. PubMed ID: 28295289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis.
    Fan J; Xu Y; Wen X; Ge S; Jia R; Zhang H; Fan X
    Mol Ther; 2019 Dec; 27(12):2182-2194. PubMed ID: 31451355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.
    Januario T; Ye X; Bainer R; Alicke B; Smith T; Haley B; Modrusan Z; Gould S; Yauch RL
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12249-12254. PubMed ID: 29087303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.
    Erkek S; Johann PD; Finetti MA; Drosos Y; Chou HC; Zapatka M; Sturm D; Jones DTW; Korshunov A; Rhyzova M; Wolf S; Mallm JP; Beck K; Witt O; Kulozik AE; Frühwald MC; Northcott PA; Korbel JO; Lichter P; Eils R; Gajjar A; Roberts CWM; Williamson D; Hasselblatt M; Chavez L; Pfister SM; Kool M
    Cancer Cell; 2019 Jan; 35(1):95-110.e8. PubMed ID: 30595504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SWI/SNF chromatin-remodeling complex acts in noncoding RNA-mediated transcriptional silencing.
    Zhu Y; Rowley MJ; Böhmdorfer G; Wierzbicki AT
    Mol Cell; 2013 Jan; 49(2):298-309. PubMed ID: 23246435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond.
    Lu P; Roberts CW
    Nucleus; 2013; 4(5):374-8. PubMed ID: 24145903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.